Drug intelligence / Profile preview

Fuke Zhidai

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Fuke Zhidai is a Traditional Chinese Medicine (TCM) product primarily indicated for gynecological conditions involving excessive vaginal discharge (leukorrhea), such as vaginitis and chronic cervicitis. The formulation typically consists of several herbal ingredients, including cortex ailanthi, cortex phellodendri, radix paeoniae alba, radix angelicae sinensis, and rhizoma atractylodis macrocephalae. In TCM theory, it functions to clear heat, dry dampness, and astringe discharge. It is produced by various manufacturers in China, including Guangdong Wannianqing Pharmaceutical and Guizhou Wansheng Pharmaceutical, and is most commonly available in tablet form (Fuke Zhidai Pian).

Brand names: Fuke Zhidai PianFuke Zhidai Tablets
Other names: Fuke Zhidai JiaonangFuke Zhidai Capsules

Beyond the preview

Go deeper on Fuke Zhidai.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuke Zhidai.

Explore the full profile